Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BVA calls for ‘holistic approach’ to drug resistance
BVA says anthelmintics and ectoparasiticides should be targeted and based on diagnostics.
A new policy position calls for more targeted parasiticide use in grazing animals.

The British Veterinary Association (BVA) has called for a holistic and evidence-based approach to parasite control in grazing animals.

The organisation has launched a new policy position on the responsible use of parasiticides in grazing animals, providing best-practice guidance for veterinary organisations and livestock owners.

As part of its policy, the BVA has advised that the use of anthelmintics and ectoparasiticides in cattle, sheep, horses and goats should be more targeted and based on diagnostics. This strategic response is to replace the use of blanket treatments at certain times of the year, which can contribute to drug resistance.

The BVA describes drug resistance as a threat to the efficacy of all parasite groups. It has mainly been reported in gastrointestinal nematodes, liver fluke, with evidence of resistance also appearing in lungworm.

There is also evidence of parasiticides affecting invertebrate species in the environment, causing wider implications for biodiversity and soil health.

Organisations which represent veterinary surgeons, livestock owners and Suitably Qualified Persons (SQPs) are asked to work with members to implement the policy guidance. Species-specific organisations are also advised to work with members to incorporate holistic parasite control into their health plans.

BVA’s policy also calls for an increased focus on diagnostics and monitoring of annual sales data, as well as a more careful assessment of product’s environmental impact.

It recommends that the SQP Code of Practice is amended to increase its emphasis on evidence-based prescribing, with reclassification of POM-Vs a possibility if necessary. It calls for the Veterinary Medicines Directorate (VMD) to work with the National Office of Animal Health (NOAH) to restrict promotion of parasiticides, and work with SQP representatives to give prescribers access to prescription histories.

Organisations working to reduce the use of antimicrobials, such as the Responsible use of Medicines in Agriculture Alliance (RUMA), are also asked to include parasticides in their remit.

Elizabeth Mullineaux, BVA president, said: "As with dogs and cats, the treatment of grazing animals with parasiticides is one of the ways in which these products enter the environment, which is why it is vital they are used appropriately, when needed, and their impact monitored.

“Maintaining the safety and efficacy of parasiticides in the future is important not only for animal health and welfare but also human health and food security.“

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.